Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
ZUMA-8: A phase 1/2 multicenter study evaluating KTE-X19 in patients (pts) with relapsed/refractory (RR) chronic lymph ocytic leukemia (CLL). Flinn, I., Marris, M., Wierda, W. G., Coutre, S., Pagel, J. M., Byrd, J. C., Goyal, L., Goodman, K., Zheng, Y., Milletti, F., Murugappan, S., Brown, J. R. AMER SOC CLINICAL ONCOLOGY. 2019
View details for Web of Science ID 000487345803433